APP and Alzheimer disease: These models are invaluable to the field but still limited in their ability to produce key AD pathologies—for example, the aforementioned study crossed their APOE mice with APP/PS1 transgenic mice in order to quantify the effects of tissue-specific APOE mutation on Aβ deposition [71].